Left Ventricular Hypertrophy

Core Idea

Left ventricular hypertrophy is an adaptive response to chronic pressure overload, increasing wall thickness to normalize wall stress. Initially compensatory, it impairs relaxation (diastolic dysfunction) and can progress to systolic dysfunction and heart failure.

How It's Best Learned

Use echocardiography to measure wall thickness and assess diastolic dysfunction. Trace the progression: concentric hypertrophy → diastolic filling impairment → dyspnea on exertion → pulmonary edema.

Common Misconceptions

LVH is not synonymous with heart failure—many patients with LVH have normal systolic function. Regression of LVH does not immediately restore diastolic function; remodeling is slow.

Explainer

From your study of the cardiac cycle, you know that the left ventricle must generate enough pressure to overcome aortic pressure and eject blood into the systemic circulation. Under normal conditions, this is a well-calibrated mechanical task. When chronic pressure overload is imposed — most commonly by hypertension, but also by aortic stenosis — the left ventricle faces a persistently higher afterload. Each beat requires more wall tension to generate the same ejection. The ventricle responds the only way muscle can respond to a chronic mechanical challenge: it grows.

This growth is concentric hypertrophy — cardiomyocytes add sarcomere units in parallel with existing ones, increasing fiber diameter and thickening the wall without enlarging the chamber cavity. The driving physics come from the law of Laplace: wall stress equals (pressure × radius) / (2 × wall thickness). By increasing wall thickness in proportion to the elevated pressure, the ventricle normalizes stress per unit of wall. This is the same logic behind training adaptation in athletes, except that physiologic (exercise-induced) hypertrophy is a healthy, self-limiting response, while pathologic hypertrophy driven by hypertension is progressive, accompanied by fibrosis, and carries different downstream consequences.

The adaptation is compensatory but not benign. Hypertrophied myocardium is stiffer than normal myocardium — collagen deposition within the wall (interstitial fibrosis) increases wall rigidity. During diastole, when the ventricle should passively relax and fill with blood from the left atrium, a stiff wall resists this relaxation. The result is diastolic dysfunction: the ventricle requires elevated filling pressures (elevated left atrial pressure) to achieve adequate end-diastolic volume. The left atrium, chronically overloaded, enlarges. Elevated pressures back up into the pulmonary veins, causing fluid to leak into the lungs — this is why patients with LVH develop dyspnea on exertion and, eventually, pulmonary edema, even while the ventricle is still squeezing normally (preserved ejection fraction).

The critical clinical insight is that LVH lies on a continuum from compensation to decompensation. For years, a patient may have severe LVH on echocardiography yet be minimally symptomatic because systolic function is intact. The danger is that the remodeled ventricle is now fragile — reduced coronary reserve (because the hypertrophied muscle outstrips its vascular supply), increased arrhythmia risk, and reduced ability to tolerate additional insults. Eventually, the hypertrophic response may fail: the wall can no longer keep pace with pressure demands, the chamber dilates (eccentric remodeling), ejection fraction falls, and the patient transitions into overt systolic heart failure. Treatment of the underlying cause — antihypertensive therapy, valve replacement — can produce partial regression of LVH over months to years, but diastolic function recovers slowly because fibrosis does not reverse as readily as myocyte mass recedes.